Compound ID | 143
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Lipopolysaccharide synthesis inhibitor. LpxC inhibitor |
| Institute where first reported: | Achaogen, USA |
| Year first mentioned: | 2012 |
| Highest development stage: | Phase 1 |
| Development status: | Withdrawn |
| Reason dropped: | Toxicity |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/71466517 |
| Guide to Pharmacology: | ACHN-975 |
| Citations: |
|